FindMyKOL
Clinical trialNCT04051138CompletedInterventional

The Effect of VOXX/eSmartr High Performance Technology on Sports Vision Ability

NCT04051138 is an interventional trial sponsored by ChampionsEdge, LLC. As of 21 Nov 2026, it is completed. It studies Sports Medicine and Vision, Binocular. The registry lists an enrollment of 50 participants at 1 site in 1 country. The registry lists a start date of 15 Aug 2019 and a primary completion date of 30 Oct 2019.

SponsorChampionsEdge, LLCEnrollment50Sports MedicineVision, Binocular
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04051138
FieldValue
Registry IDNCT04051138
StatusCompleted
Study typeInterventional trial
Lead sponsorChampionsEdge, LLC
Enrollment50
Registered sites1
Countries1
ConditionsSports Medicine and Vision, Binocular
Start15 Aug 2019
Primary completion30 Oct 2019
Study completion30 Oct 2019
Last update posted27 Jan 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to compare the effect of Voxx/eSmartr technology on common measures of sports vision performance including (Hand-Eye Coordination/Reaction time, visual concentration and basic visual functions of size detection and contrast sensitivity). The study will be a randomized, prospective, double-blind design in order to determine the effect of this technology on a subject's sports vision ability.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • Sportsvisionnyc

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04051138

Each answer restates registry values shown on this page.

What is NCT04051138?

NCT04051138 is an interventional trial sponsored by ChampionsEdge, LLC. It studies Sports Medicine and Vision, Binocular.

Who leads NCT04051138?

The registry names Daniel M Laby, MD (principal investigator, ChampionsEdge, LLC) as the overall official.

Where does NCT04051138 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT04051138 end?

The registry lists a primary completion date of 30 Oct 2019 and a study completion date of 30 Oct 2019. The sponsor last updated the record on 27 Jan 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.